David T. Huang, MD, MPH

  • Professor of Critical Care Medicine and Emergency Medicine
  • Director, Multidisciplinary Acute Care Research Organization (MACRO)
  • Faculty member, CRISMA
  • Director, CTSI Trial Innovation Unit, University of Pittsburgh
  • Associate Medical Director, Transplant Intensive Care Unit, UPMC Presbyterian-Montefiore

    Education & Training

  • BS, Nutrition Science, Cornell University, 1994
  • MD, New York Medical College, 1998
  • Residency, Emergency Medicine, Henry Ford Hospital, 2001
  • Fellowship, Critical Care Medicine, University of Pittsburgh, 2003
  • NIH T32 Research Fellowship, Critical Care Medicine, University of Pittsburgh, 2004
  • MPH, University of Pittsburgh, 2004
Fellow of the Year, American Academy of Emergency Medicine Resident, 2002
Young Investigator Award, American College of Emergency Physicians Emergency Medicine Foundation, 2006
Peter Reizenstein Prize, International Society for Quality in Health Care, 2010
Clinical Research Achievement Award (for ProCESS trial; co-investigator), 2015
Representative Publications

Huang DT, Yealy DM, Filbin MR, Brown AM, Chang CC, Doi Y, Donnino MW, Fine J, Fine MJ, Fischer MA, Holst JM. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection. New England Journal of Medicine. 2018 May 20.

Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD, Hou PC. Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome. Annals of the American Thoracic Society. 2017 Jan;14(1):124-33.

ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. New England Journal of Medicine. 2014 May 1;370(18):1683-93.

UPMC REMAP-COVID Group, on behalf of the REMAP-CAP Investigators. Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system-lessons learned and recommendations. Trials. 2021 Jan 28;22(1):100. doi: 10.1186/s13063-020-04997-6. Erratum in: Trials. 2021 Feb 16;22(1):145. PMID: 33509275; PMCID: PMC7841377.

Research Interests
  • Clinical trials
  • Resuscitation and biomarkers of sepsis
  • Neuromuscular blockade and ARDS
  • COVID-19